Lipa

(redirected from Lysosomal Acid Lipase)
Also found in: Dictionary, Medical, Acronyms.

Lipa

A subdivision of the Croatian kuna. A lipa is equal in value to 1/100 of a kuna. See also: Cent.
References in periodicals archive ?
Synageva") (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, today announced six month results from an ongoing extension study of sebelipase alfa in adults with late onset Lysosomal Acid Lipase (LAL) Deficiency at the American Association for the Study of Liver Diseases (AASLD) annual meeting being held in Boston, MA, November 9-13, 2012.
Co-Localization of Macrophage Aggregation and Fibrosis in a Rat Model of Lysosomal Acid Lipase (LAL) Deficiency and the Effects of Enzyme Replacement with SBC-102," J.
Each year, Synageva joins efforts with The Global Genes Project, a leading non-profit organization for rare and genetic diseases, in a volunteer fundraiser with proceeds to benefit the Support Organization for Lysosomal Acid Lipase Deficiency Advocacy, Care and Expertise (LAL Solace) organization and other LAL Deficiency patient organizations and patient advocacy groups.
Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.
Patients with Morquio syndrome A and lysosomal acid lipase (LAL) deficiency are first in line to benefit from the emergence of novel treatments, with the respective launches of Vimizim (BioMarin's elosulfase alfa) and Kanuma (Alexion/Synageva's sebelipase alfa) in 2014 and 2015 respectively.
Food and Drug Administration (FDA) for sebelipase alfa as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.
Along with displaying the signature Blue Denim Genes Ribbon[TM] associated with The Global Genes Project, Synageva employees will participate in a volunteer fund-raiser with proceeds to benefit the Support Organization for Lysosomal Acid Lipase Deficiency Advocacy, Care and Expertise (LAL Solace), a patient advocacy group for individuals affected by lysosomal acid lipase deficiency (LAL Deficiency).
Full browser ?